Beaman M, Solaro L, McGonigle R J, Michael J, Adu D
Department of Nephrology, Queen Elizabeth Hospital, Birmingham, UK.
Nephron. 1989;51(1):51-5. doi: 10.1159/000185242.
102 episodes of continuous ambulatory peritoneal dialysis (CAPD) peritonitis were studied prospectively during a 288-day period at The Queen Elizabeth Hospital, Birmingham. Organisms were isolated from 76% of the episodes, with coagulase-negative staphylococci, being the most commonly encountered organism (55%). Initial treatment consisted of intraperitoneal vancomycin and ceftazidime with subsequent adjustment on the basis of antibiotic sensitivities. With this regimen, 83% of the positive cultures became negative by 72 h, 9.8% of cases relapsed and removal of the CAPD catheter was necessary in 8 patients (7.8%). Overall, 92% of cases were cured. No adverse drug reactions were seen. This combination of antibiotics appears effective and safe in the treatment of CAPD peritonitis.
在伯明翰伊丽莎白女王医院进行的一项为期288天的前瞻性研究中,对102例持续性非卧床腹膜透析(CAPD)腹膜炎病例进行了研究。76%的病例中分离出了微生物,凝固酶阴性葡萄球菌是最常见的微生物(55%)。初始治疗包括腹腔内使用万古霉素和头孢他啶,随后根据抗生素敏感性进行调整。采用该治疗方案,83%的阳性培养物在72小时内转阴,9.8%的病例复发,8例患者(7.8%)需要拔除CAPD导管。总体而言,92%的病例治愈。未观察到药物不良反应。这种抗生素联合用药在治疗CAPD腹膜炎方面似乎有效且安全。